Author: Elliott Pendleton - Page 2

Combo generics often cost far more than buying the same drugs as separate generics. Learn how much you could save by switching - and when combos are actually worth the price.

Triptans are effective for migraines but come with serious interactions and limitations. Learn when they work, when they don’t, and what to avoid-especially if you’re on antidepressants or have heart risks.

Learn how to create a safe medication routine at home to prevent accidental poisonings and dosing errors. Simple steps like locking up meds, using pill organizers, and keeping a master list can protect your whole family.

Learn which medications to avoid during pregnancy and what safe alternatives exist for pain, allergies, depression, and more. Updated with 2025 FDA guidance on acetaminophen and NSAIDs.

Long-term safety studies show mixed results when comparing generic and brand-name drugs. While most generics are safe, real-world data reveals important differences in outcomes-especially for critical medications and those made overseas.

Drug safety signals reveal hidden risks that clinical trials miss. Learn how real-world data, statistical tools, and regulatory systems uncover dangerous side effects after a drug is approved.

The FDA ensures generic drug safety through strict manufacturing oversight, bioequivalence testing, global inspections, and post-market surveillance. Learn how every generic pill meets the same standards as brand-name drugs.

Sarcopenia worsens COPD outcomes by reducing strength and mobility. Learn how targeted nutrition (1.2-1.5g protein/kg/day) and low-intensity resistance training can improve muscle mass, walking ability, and survival rates.

Discover how RFID, eMAR, and mobile apps help track medication expiration dates to prevent waste and ensure patient safety. Learn which systems work best for hospitals, clinics, and home use.

Generic drug shortages are at record levels due to fragile supply chains, low profit margins, and overreliance on foreign manufacturing. Learn why sterile injectables are most at risk and what’s being done-or not done-to fix it.